- Home
- CRT vs ANVS Comparison
CRT vs ANVS Comparison
Compare CRT & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRT
- ANVS
- Stock Information
- Founded
- CRT 1991
- ANVS 2008
- Country
- CRT United States
- ANVS United States
- Employees
- CRT N/A
- ANVS N/A
- Industry
- CRT Oil & Gas Production
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- CRT Energy
- ANVS Health Care
- Exchange
- CRT Nasdaq
- ANVS Nasdaq
- Market Cap
- CRT 65.1M
- ANVS 44.6M
- IPO Year
- CRT 1992
- ANVS 2020
- Fundamental
- Price
- CRT $9.70
- ANVS $2.36
- Analyst Decision
- CRT
- ANVS Strong Buy
- Analyst Count
- CRT 0
- ANVS 4
- Target Price
- CRT N/A
- ANVS $18.00
- AVG Volume (30 Days)
- CRT 22.2K
- ANVS 485.7K
- Earning Date
- CRT 01-01-0001
- ANVS 08-14-2025
- Dividend Yield
- CRT 9.19%
- ANVS N/A
- EPS Growth
- CRT N/A
- ANVS N/A
- EPS
- CRT 0.99
- ANVS N/A
- Revenue
- CRT $6,834,116.00
- ANVS N/A
- Revenue This Year
- CRT N/A
- ANVS N/A
- Revenue Next Year
- CRT N/A
- ANVS N/A
- P/E Ratio
- CRT $9.75
- ANVS N/A
- Revenue Growth
- CRT N/A
- ANVS N/A
- 52 Week Low
- CRT $8.88
- ANVS $1.11
- 52 Week High
- CRT $13.31
- ANVS $17.88
- Technical
- Relative Strength Index (RSI)
- CRT 41.50
- ANVS 48.29
- Support Level
- CRT $9.74
- ANVS $2.05
- Resistance Level
- CRT $9.99
- ANVS $3.18
- Average True Range (ATR)
- CRT 0.18
- ANVS 0.26
- MACD
- CRT 0.00
- ANVS -0.08
- Stochastic Oscillator
- CRT 8.11
- ANVS 27.43
About CRT Cross Timbers Royalty Trust
Cross Timbers Royalty Trust is a United States-based trust. The net profits interests are derived from producing royalty, overriding royalty interests, and working interest properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.